BDBM419233 N-(4-ethylphenyl)-N- isobutyl-3-(S- methylsulfonimidoyl)-4-(2- oxa-6-azaspiro[3.3]heptan- 6-yl)benzenesulfonamide::US10457637, Compound 111

SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(N2CC3(COC3)C2)c(c1)S(C)(=N)=O

InChI Key InChIKey=UVNTXKVJLGTIRB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 419233   

TargetNuclear receptor ROR-gamma(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM419233(N-(4-ethylphenyl)-N- isobutyl-3-(S- methylsulfonim...)
Affinity DataIC50: 100nMAssay Description:The RORγ transactivation model was developed from the line HG5LN, which is a HeLa line that stably expresses a luciferase reporter gene controll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2020
Entry Details
Go to US Patent